enzalutamide
Interviews and expert commentary tagged “enzalutamide” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Audio Journal of Oncology
Enzalutamide improves overall and progression-free survival in men with chemotherapy-naïve metastatic castration-resistant prostate cancer
SAN FRANCISCO— The orally administered androgen receptor blocker enzalutamide significantly extended both overall survival and radiographically determined progression-free survival in men whose metast
6 March 2014
0:00
Audio Journal of Oncology
Responses to enzalutamide after prior abiraterone therapy in men with castration-resistant metastatic prostate cancer
SAN FRANCISCO— Four out of ten patients whose metastatic castration resistant prostate cancer had already been treated with abiraterone responded to further ‘new generation’ androgen depri
11 February 2014
0:00